Efficacy of radiotherapy for malignant gliomas in elderly patients

International Journal of Radiation Oncology Biology Physics

Volumn 42, Issue 5, 1998, Pages 977-980

  Villà, Salvador ^a   Viñolas, Nuria ^b   Verger, Eugenia ^b   Yaya, Ricard ^b   Martínez, Antonio ^a   Gil, Miquel ^a   Moreno, Victor ^a   Caral, Luis ^b   Graus, Francesc ^b  

^a CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Age; Malignant glioma; Radiotherapy; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT; CARMUSTINE; COBALT 60; LOMUSTINE; PROCARBAZINE; VINCRISTINE;

AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; COBALT THERAPY; FEMALE; GERIATRIC PATIENT; GLIOBLASTOMA; GLIOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BRAIN NEOPLASMS; FEMALE; GLIOBLASTOMA; GLIOMA; HUMANS; MALE; SURVIVAL ANALYSIS;

EID: 0345196626     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00356-3     Document Type: Article

References (23)

1. Prognostic factors for high-grade malignant glioma Development of a prognostic index . J Neuro-Oncol. 9:1990;47-55.
2. Burger P.C., Vogel F.S., Green S.B., et al. Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications. Cancer. 56:1985;1106-1111.
3. Byar D.P., Green S.B., Strike T.A. Prognostic factors for malignant glioma. Walker M.D. Oncology of the nervous system. 1983;379-395 Martinus Nijhoff Publishers, Boston.
4. Ampil F., Fowler M., Kim K. Intracranial astrocytomas in elderly patients. J Neuro-Oncol. 12:1992;125-130.
5. Meckling S., Dold O., Forsyth P.A.J., Brasher P., Hagen N.A. Malignant supratentorial glioma in the elderly Is radiotherapy useful? Neurology. 47:1996;901-905.
6. Peschel R., Wilson L., Haffty B., Papadopoulos D., Rosenzweig K., Feltes M. The effect of advanced age on the efficacy of radiation therapy for early breast cancer, local prostate cancer and grade III gliomas. Int J Radiat Oncol Biol Phys. 26:1993;539-544.
7. Walker A.E., Robins M., Weinfeld F.D. Epidemiology of brain tumors The national survey of intracranial neoplasms . Neurology. 35:1985;219-226.
8. Greig N.H., Ries L.G., Yanick R., Rapoport S.I. Increasing annual incidence of primary malignant brain tumors in the elderly. J Natl Cancer Inst. 82:1990;1621-1624.
9. Riggs J.E. Rising primary malignant brain tumor mortality in the elderly. Arch Neurol. 52:1995;571-575.
10. Werner M.H., Phuphanich S., Lyman G.H. The increasing incidence of malignant gliomas and primary central nervous system lymphoma in the elderly. Cancer. 76:1995;1634-1642.
11. Kaplan E.L., Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
12. Cox D.R. J R Stat Soc (B). 34:1972;187-202.
13. Viñolas N., Arbaiza D., Graus F., et al. Tratamiento quirúrgico combinado con radioterapia y quimioterapia en una población no seleccionada de pacientes con glioma maligno. Surgical treatment combined with radiotherapy and chemotherapy in an unselected population of patients with malignant glioma. Med Clin. 101:1993;641-643.
14. Winger M.J., Macdonald D.R., Schold S.C., Cairncross J.G. Selection bias in clinical trials of anaplastic glioma. Ann Neurol. 26:1989;531-534.
15. Ammirati M., Vick N., Liao Y., Ciric I., Mikhael M. Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas. Neurosurgery. 21:1987;201-206.
16. Kelly P.J., Hunt C. The limited value of cytoreductive surgery in elderly patients with malignant gliomas. Neurosurgery. 34:1994;62-72.
17. Fadul C., Wood J., Thaler H., Galicich J., Patterson R.H., Posner J.B. Morbidity and mortality of craniotomy for excision of supratentorial gliomas. Neurology. 38:1988;1374-1379.
18. Whittle I.R., Denholm S.W., Gregor A. Management of patients over 60 years with supratentorial glioma Lessons from an audit . Surg Neurol. 36:1991;106-111.
19. Pierga JY, Hoang-Xuan K, Simon JM; et al. Treatment of malignant gliomas in the elderly (> 70 years) (Abstr.). Neurology 1997;48:A27.
20. Curran W.J., Scott ChB, Horton J., et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst. 85:1993;704-710.
21. Kleinberg L., Slick T., Enger C., Grossman S., Brem H., Wharam M.D. Short course radiotherapy is an appropriate option for most malignant glioma patients. Int J Radiat Oncol Biol Phys. 38:1997;31-36.
22. Buatti J.M., Marcus R.B., Mendenhall W.M., Friedman W.A., Bova F.J. Accelerated hyperfractionated radiotherapy for malignant gliomas. Int J Radiation Oncol Biol Phys. 34:1996;785-792.
23. Curran W.J., Scott ChB, Nelson J.S., et al. A randomized trial of accelerated hyperfractionated radiation therapy and bis-chlorethyl nitrosourea for malignant glioma. Cancer. 70:1992;2909-2917.